Stay updated on ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Locations section updated to include North Dakota, Western Australia, and Veliko Tarnovo (revision 3.3.3). HHS Vulnerability Disclosure and related location entries (North Dakota, Western Australia, Veliko Tarnovo) were removed (revision 3.3.2).
    Difference
    0.4%
    Check dated 2025-12-23T01:29:00.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:29:32.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Publications section wording was updated to indicate items are automatically filled from PubMed, and the revision tag was updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:59:25.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH/CC operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:21:35.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page; the study details and eligibility criteria appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T00:53:51.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Updated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.
    Difference
    3%
    Check dated 2025-10-05T07:59:25.000Z thumbnail image

Stay in the know with updates to ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.